Existing drug treatments cannot significantly shorten the clinical cure time of children with COVID-19 | Zendy

Mengting Li | Zendy; Yang Wang | Zendy; Hua Xu | Zendy; Changlin Liu | Zendy; Liang Shi | Zendy; Qi Ye | Zendy; Jun Wang | Zendy; Sichan Li | Zendy; Mei Yan | Zendy; Liuliu Gao | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Existing drug treatments cannot significantly shorten the clinical cure time of children with COVID-19

Author(s) -

Mengting Li,

Yang Wang,

Hua Xu,

Changlin Liu,

Liang Shi,

Qi Ye,

Jun Wang,

Sichan Li,

Mei Yan,

Liuliu Gao

Publication year - 2020

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.13491

Subject(s) - medicine , cure rate , covid-19 , drug , epidemiology , mortality rate , intensive care medicine , pharmacology , disease , infectious disease (medical specialty)

COVID-19 has become a global health security issue, it has caused more than half a million deaths worldwide so far, the treatment strategies are the most concerned issues for clinicians. In this study, the treatments and outcomes in 40 pediatric patients diagnosed with COVID-19 and treated with different drugs were evaluated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research